Angels Partners logo
  • Find Angel Investors
    • Find Angel Investors in the US
    • Find Angel Investors in the UK
    • Find Angel Investors in Europe
      Find Angel Investors in DenmarkFind Angel Investors in FinlandFind Angel Investors in FranceFind Angel Investors in GermanyFind Angel Investors in ItalyFind Angel Investors in NetherlandsFind Angel Investors in SwedenFind Angel Investors in Switzerland
    • Find Angel Investors in Canada
    • Find Angel Investors in Australia
  • Top VC Firms
    Top AI VC firmsTop BioTech VC firmsTop CleanTech VC firmsTop Cyber Security VC firmsTop E-commerce VC firmsTop HealthTech VC firmsTop FinTech VC firmsTop Food Industry VC firmsTop Robotics VC firmsTop SaaS VC firmsTop Transportation VC firms
  • Pricing
  • Products
    Investor CommunityInvestor DatabaseAutomationWarm IntrosFounder CommunityDocument SharingLegal Templates
  • FAQ
  • Blog
  • About
  • Sign up
  • Log in
Are you an

  • Entrepreneur
  • Investor
< Browse Firms
Logo Firm Juno Therapeutics
websitelinkedinfacebooktwittergoogle

Juno Therapeutics

map marker logo Seattle |  U.S.A.

Investor TypeFirm
StagesSeries A
InvestingUnited States
Investment Range $47,000,000  -  $47,000,000

How to connect with investors at Juno Therapeutics?

Discover introductions paths, using your LinkedIn network, work your way to investors you can get connected to


Generate Warm Introductions >

What is Juno Therapeutics?

Juno Therapeutics operates as a clinical-stage company that focuses on developing a broad pipeline of innovative cancer immunotherapies. They bring together the expertise of three leading cancer centers - Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center, and Seattle Children's Research Institute to revolutionize cancer treatment.

By harnessing the body's own immune system to fight cancer, Juno aims to develop two distinct, yet complementary platforms: Chimeric Antigen Receptor (CAR) technology and T-cell Receptor (TCR) technology. With one of the largest Series A investments in biotech history, Juno has made significant strides in advancing these therapies.

Investing solely in Series A ventures, they have a clearly defined investment profile with both minimum and maximum fund investments pegged at $47,000,000, signaling a focused and substantial commitment to their selected ventures. Juno's mission is integrated into the larger framework of the global biopharmaceutical company Bristol Myers Squibb.

The acquisition by Bristol Myers Squibb positions Juno within an expansive portfolio that extends beyond oncology, covering areas such as hematology, immunology, cardiovascular disease, and fibrosis. Together, they work towards transforming patient lives through science and have been involved in crucial advancements in the industry such as the latest FDA approvals for oncology treatments and the development of new therapy administration methods.

Shareholders and investors are engaged through detailed financial reporting, regular updates on investments, and the potential for long-term growth through pioneering treatments. The firm's dedication to medical research, support for researchers with grants and resources, initiatives to drive STEM education, and fostering diversity in science underscores their commitment to innovation and societal impact

Juno Therapeutics's investments on record

Editas Medicine $47,000,000.00 Funding Round
Tweets by Juno Therapeutics

What are the investment firms similar to Juno Therapeutics

Similar Investor NYU Stern School of Business
NYU Stern School of Business
Similar Investor Health2047
Health2047
Similar Investor Alantra
Alantra
Similar Investor Qualtrics
Qualtrics
Similar Investor Acronym Venture Capital
Acronym Venture Capital
Similar Investor Geopay.me
Geopay.me
Similar Investor 7BC Venture Capital
7BC Venture Capital
Similar Investor HV Capital
HV Capital
Similar Investor Invisto
Invisto
angels partners Overview

Contact over 100,000 investors!

Built by serial entrepreneurs and ex-VCs, Angels Partners helps entrepreneurs connect with relevant investors in their industry.

With over 100K+ listed investors, our mission is to help founders secure meetings & accelerate their fundraising.

View previous deals, filter by deal size, industry, location and more. It's the fastest way to build a target investor list.

e We also built a community of hundreds of investors actively prospecting & investing directly on Angels Partners.

 

Register to become visible to a large community of investors on our platform.

  • Sign up
  • Log in
  • Prime Founders
  • 85 Great Portland St.
  • London, U.K.
  •   contact@angelspartners.com
  • About Us
  • Terms & Conditions
  • Privacy Policy
  • Editorial Process
  • Contact Us
Copyright © 2024 - All trademarks and copyrights belong to their respective owners.
proof notifcation
32 New StartupsStarted their fundraisingover the last 7 daysproof logo